Esther Welkowsky
Director Técnico/Científico/I+D en ELICIO THERAPEUTICS, INC. .
Perfil
Esther Welkowsky is currently the Vice President-Clinical Development at Elicio Therapeutics, Inc. (United States) and the Senior Vice President-Clinical Development at Elicio Therapeutics, Inc. She previously worked as the Executive Director-Clinical Operations at Allogene Therapeutics, Inc. from 2018 to 2020.
Prior to that, she was the Head-Clinical Operations at Atara Biotherapeutics, Inc. Ms. Welkowsky completed her undergraduate degree at the University of California, Santa Barbara.
Cargos activos de Esther Welkowsky
| Empresas | Cargo | Inicio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2020 |
Antiguos cargos conocidos de Esther Welkowsky.
| Empresas | Cargo | Fin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
| ATARA BIOTHERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Formación de Esther Welkowsky.
| University of California, Santa Barbara | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Esther Welkowsky